Protein kinases | Early recurrence | Late recurrence | No recurrence | Â | p value | Â |
---|---|---|---|---|---|---|
n = 31 | n = 27 | n = 132 | Early vs No recurrence | Late vs No recurrence | Early vs Late recurrence | |
EGFR | ||||||
 Low | 14 (45) | 19 (70) | 88 (67) | 0.038 | 0.824 | 0.067 |
 High | 17 (55) | 8 (30) | 44 (33) |  |  |  |
HER2 | ||||||
 Low | 14 (45) | 7 (26) | 64 (49) | 0.842 | 0.035 | 0.174 |
 High | 17 (55) | 20 (74) | 68 (51) |  |  |  |
HER3 | ||||||
 Low | 22 (71) | 18 (67) | 86 (65) | 0.674 | 1.000 | 0.781 |
 High | 9 (29) | 9 (33) | 46 (35) |  |  |  |
HER4 | ||||||
 Low | 15 (48) | 17 (63) | 93 (71) | 0.033 | 0.495 | 0.300 |
 High | 16 (52) | 10 (37) | 39 (29) |  |  |  |
VEGFR3 | ||||||
 Low | 25 (81) | 21 (78) | 93 (71) | 0.372 | 0.493 | 1.000 |
 High | 6 (19) | 6 (22) | 39 (29) |  |  |  |
VEGF-C | ||||||
 Low | 12 (39) | 8 (30) | 54 (41) | 1.000 | 0.387 | 0.583 |
 High | 19 (61) | 19 (70) | 78 (59) |  |  |  |
EphA3 | ||||||
 Low | 12 (39) | 15 (56) | 86 (65) | 0.008 | 0.384 | 0.292 |
 High | 19 (61) | 12 (44) | 46 (35) |  |  |  |
EphrinA1 | ||||||
 Low | 16 (52) | 14 (52) | 61 (46) | 0.690 | 0.674 | 1.000 |
 High | 15 (48) | 13 (48) | 71 (54) |  |  |  |
p-Akt1 | ||||||
 Low | 9 (29) | 5 (19) | 55 (42) | 0.225 | 0.029 | 0.378 |
 High | 22 (71) | 22 (81) | 77 (58) |  |  |  |
Akt1 | ||||||
 Low | 16 (52) | 14 (52) | 66 (50) | 1.000 | 1.000 | 1.000 |
 High | 15 (48) | 13 (48) | 66 (50) |  |  |  |
Cytoplasmic beta-catenin | ||||||
 Negative | 27 (87) | 22 (82) | 108 (82) | 0.603 | 1.000 | 0.720 |
 Positive | 4 (13) | 5 (18) | 24 (18) |  |  |  |
Membranous beta-catenin | ||||||
 Negative | 28 (90) | 25 (93) | 121 (92) | 0.731 | 1.000 | 1.000 |
 Positive | 3 (10) | 2 (7) | 11 (8) |  |  |  |
Nuclear beta-catenin | ||||||
 Negative | 31 (100) | 27 (100) | 129 (98) | 1.000 | 1.000 | NA |
 Positive | 0 (0) | 0 (0) | 3 (2) |  |  |  |
Wnt5a | ||||||
 Low | 16 (52) | 9 (33) | 68 (51) | 1.000 | 0.095 | 0.192 |
 High | 15 (48) | 18 (67) | 64 (49) |  |  |  |